Long-term efficacy and safety of osilodrostat in patients with Cushing’s disease: results from the LINC 4 study extension

By sjmartinez • September 8, 2023

Gadelha M, Snyder PJ, Witek P, Bex M, Belaya Z, Turcu AF, Feelders RA, Heaney AP, Paul M, Pedroncelli AM, Auchus RJ. Long-term efficacy and safety of osilodrostat in patients with Cushing's disease: results from the LINC 4 study extension. Front Endocrinol (Lausanne). 2023 Aug 23;14:1236465. doi: 10.3389/fendo.2023.1236465. PMID: 37680892; PMCID: PMC10482037.

Tags: 11β-hydroxylase, Cushing’s disease, Digestive Diseases, hypercortisolism, long-term treatment, osilodrostat, Publications

Extracellular vesicle digital scoring assay for assessment of treatment responses in hepatocellular carcinoma patients

Zhao C, Lee YT, Melehy A, Kim M, Yang JZ, Zhang C, Kim J, Zhang RY, Lee J, Kim H, Ju Y, Tsai YJ, Zhou[...]

Towards precision medicine in clinical trials for the treatment of urologic chronic pelvic pain syndrome: lessons from the MAPP Research Network

Stephens Shields AJ, Clemens JQ, Pontari MA, Lai HH, Moldwin R, Williams DA, Bradley CS, Farrar JT, Landis JR, Mullins C, Naliboff BD, Sutcliffe S,[...]

Treatment of alcohol use disorder in alcohol-associated liver disease: A meta-analysis

Singal AK, Zhang W, Shetty A, Patel A, Mohammed S, Bhandari P, Abdallah M, Vatsalya V, Leggio L, Kong M. Treatment of alcohol use disorder[...]